Laxmi Dental Q1 FY27 Revenue Surges 13.9% YoY to ₹74.7 Crore
Laxmi Dental reported Q1 FY27 consolidated revenue of ₹74.7 crore, up 13.9% YoY. EBITDA increased 20.6% to ₹14.4 crore. PAT grew 23.8% to ₹10.3 crore. Dental Laboratory business grew 23.5% and Aligner Solutions business grew 28.6%. The company plans to strengthen its U.S. presence and expand operations in India.
The announcement details strong financial performance and growth across key business segments, which is positive for investors. However, it does not include any major strategic shifts or transformative events that would warrant a 'High' impact.
The company reported its highest-ever quarterly revenue with strong year-on-year growth in revenue, EBITDA, and PAT. Key business segments also showed significant growth, indicating positive business momentum.
Laxmi Dental Limited announced its unaudited consolidated financial results for the quarter ended June 30, 2026. The company reported its highest-ever quarterly revenue, reaching ₹74.7 crore (INR 747.0 million), a 13.9% increase year-on-year. EBITDA grew by 20.6% to ₹14.4 crore (INR 143.6 million), with the EBITDA margin improving to 19.2% from 18.2% in the prior year quarter.
Profit Before Tax (PBT) increased by 25.5% to ₹12.0 crore (INR 120.4 million). Profit After Tax (PAT) saw a significant jump of 23.8% to ₹10.3 crore (INR 103.2 million), leading to an improved PAT margin of 13.8% compared to 12.7% in Q1 FY26.
The company highlighted strong performance in its Dental Laboratory business, which grew by 23.5% year-on-year, with international operations showing robust growth of 37.4%. The Aligner Solutions business also maintained momentum, growing 28.6% year-on-year.
Management commentary emphasized a focus on strengthening the U.S. market presence and expanding support facilities in India to enhance market penetration and customer service. Future strategies include a focus on the core dental portfolio, AI-led automation, and improving operational efficiencies to ensure sustainable performance.
What to do with a filing like this
Laxmi Dental Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Laxmi Dental Limited. Read the original for the full detail.